Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced / Metastatic Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01125891
What this trial is testing

Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors

Who this might be right for
Malignant NeoplasmasSolid Tumors
Traws Pharma, Inc. 39
Early research (Phase 1)UnknownNCT05468190
What this trial is testing

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 48
Early research (Phase 1)Looking for participantsNCT06826313
What this trial is testing

Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Guangzhou Virotech Pharmaceutical Co., Ltd. 12
Early research (Phase 1)Study completedNCT04648254
What this trial is testing

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer
Qurient Co., Ltd. 51
Early research (Phase 1)Study completedNCT01245205
What this trial is testing

Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+4 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Looking for participantsNCT06566079
What this trial is testing

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

Who this might be right for
Malignant MesotheliomaMetastatic Malignant Solid TumorAdvanced Solid Tumor
InSilico Medicine Hong Kong Limited 160
Early research (Phase 1)Not Yet RecruitingNCT07462442
What this trial is testing

Study of QLS5308 in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Qilu Pharmaceutical Co., Ltd. 192
Early research (Phase 1)Ended earlyNCT06585488
What this trial is testing

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

Who this might be right for
Metastatic Solid TumorsAdvanced Non-squamous Non-small-cell Lung CancerAdvanced Colorectal Cancer+4 more
BeOne Medicines 47
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Early research (Phase 1)Study completedNCT02482441
What this trial is testing

A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10

Who this might be right for
Advanced Relapsed TumorsRefractory Solid Tumors
OncoMed Pharmaceuticals, Inc. 50
Early research (Phase 1)Ended earlyNCT04931823
What this trial is testing

Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Conjupro Biotherapeutics, Inc. 34
Testing effectiveness (Phase 2)Looking for participantsNCT06827613
What this trial is testing

Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors

Who this might be right for
Triple Negative Locally Advanced Non-resectable Breast CancerHR+, HER2-, Advanced Breast Cancer
Marengo Therapeutics, Inc. 50
Early research (Phase 1)UnknownNCT05263180
What this trial is testing

EMB-09 in Participants With Advanced or Metastatic Solid Tumors.

Who this might be right for
Advanced Solid Tumor
Shanghai EpimAb Biotherapeutics Co., Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT07602842
What this trial is testing

IDP-001 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more
InduPro, Inc. 132
Early research (Phase 1)Study completedNCT02220049
What this trial is testing

Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Gustave Roussy, Cancer Campus, Grand Paris 18
Early research (Phase 1)Study completedNCT04336098
What this trial is testing

Study of SRF617 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Coherus Oncology, Inc. 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT03673787
What this trial is testing

A Trial of Ipatasertib in Combination With Atezolizumab

Who this might be right for
Solid TumorGlioblastoma MultiformeProstate Cancer Metastatic
Institute of Cancer Research, United Kingdom 87
Early research (Phase 1)Study completedNCT01199822
What this trial is testing

Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors

Who this might be right for
MalignancyMetastasis
Eli Lilly and Company 16
Early research (Phase 1)Study completedNCT00003712
What this trial is testing

CCI-779 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
The University of Texas Health Science Center at San Antonio 15
Early research (Phase 1)Active Not RecruitingNCT06818812
What this trial is testing

Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Who this might be right for
Solid Tumors
Incyte Corporation 30
Next Page